Skip to main content
. Author manuscript; available in PMC: 2021 Jul 28.
Published in final edited form as: Am Econ J Econ Policy. 2018 Nov;10(4):1–35. doi: 10.1257/pol.20170082

Table 5:

OxyContin Misuse and Changes in Synthetic Opioid Death Rates

Outcome: Overdose Deaths per 100,000
(1) (2) (3) (4) (5) (6)
A. Synthetic Opioid Deaths per 100,000 (T40.4)
Initial OxyContin (3 Year Effect) 0.454 (0.405) 0.616* (0.366) 0.641* (0.349) 0.869* (0.444) 1.137*** (0.262) 1.223*** (0.339)
Initial Pain Reliever (3 Year Effect) −0.106 (0.108) −0.085 (0.082)
Mean of Dep. Variable (2008–09): 0.887
B. Synthetic Opioid-Only Deaths per 100,000 (T40.4, but not also T40.1, T40.2, or T40.3)
Initial OxyContin (3 Year Effect) 0.124 (0.257) 0.245 (0.223) 0.267 (0.214) 0.363 (0.243) 0.933*** (0.234) 0.944*** (0.240)
Initial Pain Reliever (3 Year Effect) −0.044 (0.063) −0.023 (0.066)
Mean of Dep. Variable (2008–09): 0.624

State and Time-Varying Covariates No Yes Yes Yes Yes Yes
Policy Variables No No Yes Yes Yes Yes
Estimator OLS OLS OLS OLS Poisson Poisson

Notes: Standard errors in parentheses adjusted for clustering at the state-level. State fixed effects and year fixed effects included in all specifications. Each model also includes a linear trend interacted with initial nonmedical OxyContin misuse as well as a post-2011 indicator interacted with initial nonmedical OxyContin misuse. Finally, a separate post-2011 linear trend interacted with initial nonmedical OxyContin misuse is also included. We report the 3 year post-2011 effect of the initial OxyContin variable. Regressions are weighted by population. Years 2008–2013 are used.

***

Significant at the 1% level

**

Significant at the 5% level

*

Significant at the 10% level.